Dosimetry and toxicology of ultrafine particles

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 2, 2004, Pages 140-152

  Kreyling, Wolfgang G ^a   Semmler, Manuela ^a   Möller, Winfried ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Ambient aerosols; Combustion aerosols; Health effects; Inflammation; Inhalation; PM2.5; Translocation; Ultrafine particles

Indexed keywords

AEROSOL; CATALYSIS; CELL ACTIVATION; CONFERENCE PAPER; DOSIMETRY; EPIDEMIOLOGICAL DATA; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; LUNG CLEARANCE; LUNG FUNCTION TEST; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PATHOPHYSIOLOGY; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SURFACE PROPERTY; URBAN AREA;

AEROSOLS; AIR POLLUTANTS; ANIMALS; ENVIRONMENTAL MONITORING; HUMANS; INHALATION EXPOSURE; LUNG DISEASES; PARTICLE SIZE; PRIMARY PREVENTION; RATS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES;

EID: 3242720289     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/0894268041457147     Document Type: Conference Paper

References (80)

1. Pope, C.A., III, D.W. Dockery, and J. Schwartz. 1995. Review of epidemiological evidence of health effects of particulate air pollution. Inhal. Toxicol. 7:1-18.
2. Pope, C.A., III, and D.W. Dockery. 1999. Epidemiology and particle effects. In S.T. Holgate, J.M. Samet, H.S. Koren, et al., eds. Air Pollution and health. Academic Press, San Diego, 673-705.
3. Pope, C.A., III. 2000. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk? Environ. Health Perspect. 108: 713-723.
4. Samet, J.M., S.L. Zeger, F. Dominici, et al. 2000. The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States. Research report/HEI 94(Pt 2):5-79.
5. Green, L.C., E.A. Crouch, M.R. Ames, et al. 2002. What's wrong with the National Ambient Air Quality Standard (NAAQS) for fine particulate matter (PM(2.5))? Regul. Toxicol. Pharmacol. 35:327-337.
6. Wichmann, H.E., C. Spix, T. Tuch, et al. 2000. Daily mortality and fine and ultrafine particles in erfurt, germany part I: role of particle number and particle mass. Research report/HEI 98:5-86.
7. Wichmann, H.E., and A. Peters. 2000. Epidemiological evidence of the effects of ultrafine particle exposure. Phil. Trans. R. Soc. A 358:2751-2769.
8. Cyrys, J., M. Stölzel, J. Heinrich, et al. 2003. Elemental composition and sources of fine and ultrafine particles in Erfurt, Germany. Sci. Total Environ. 305:143-156.
9. Siegmann, K., and H.C. Siegmann. 1997. The formation of carbon in combustion and how to quantify the impact on human health. Europhysics News 28:50-57.
10. Kittelson, D.B. 1998. Engines and nanoparticles: a review. J. Aerosol Sci. 29:575-588.
11. Harrison, R.M., J.P. Shi, S. Xi, et al. 2000. Measurement of number, mass and size distribution of particles in the atmosphere. Phil. Trans. R. Soc. A 358:2567-2580.
12. Sawyer, R.F., and J.J. Johnson. 1995. Diesel emission and control techniques. Diesel exhaust: critical analysis of emissions, exposure, and health effects. Health Effect Institute (HEI). 65-81.
13. Kreyling, W.G., T. Tuch, A. Peters, et al. 2003. Diverging long-term trends in ambient urban particle mass and number concentrations associated with emission changes caused by the German unification. Atmos. Environ. 37:3841-3848.
14. Fuchs, N.A. 1964. The Mechanics of Aerosols. Pergamon Press, New York.
15. Heyder, J., J. Gebhart, G. Rudolf, et al. 1986. Deposition of particles in the human respiratory tract in the size range 0.005-15 microns. J. Aerosol Sci. 17:811-825.
16. Rudolf, G., J. Gebhart, J. Heyder, et al. 1986. An empirical formula describing aerosol deposition in man for any particle size. J. Aerosol Sci. 17:350-355.
17. Schiller, C.F., J. Gebhart, J. Heyder, et al. 1986. Factors influencing total deposition of ultrafine aerosol particles in the human respiratory tract. J. Aerosol. Sci. 17:328-332.
18. ICRP. 1994. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann. ICRP 24:1-482.
19. Jaques, P.A., and C.S. Kim. 2000. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal. Toxicol. 12:715-731.
20. Butterweck, G., G. Vezzu, C. Schuler, et al. 2001. In vivo measurement of unattached radon progeny deposited in the human respiratory tract. Radiat. Prot. Dosimetry 94:247-250.
21. Brown, J.S., K.L. Zeman, and W.D. Bennett. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 166:1240-1247.
22. Daigle, C.C., D.C. Chalupa, F.R. Gibb, et al. 2003. Ultrafine particle deposition in humans during rest and exercise. Inhal. Toxicol. 15:539-552.
23. Bennett, W.D., K.L. Zeman, and C. Kim. 1996. Variability of fine particle deposition in healthy adults: effect of age and gender. Am. J. Respir. Crit. Care Med. 153:1641-1647.
24. Lehnert, B.E., Y.E. Valdez, and G.L. Tietjen. 1989. Alveolar macrophage-particle relationships during lung clearance. Am. J. Respir. Cell Mol. Biol. 1:145-154.
25. Lehnert, B.E., J.B. Ortiz, J.A. Steinkamp, et al. 1992. Mechanisms underlying the particle redistribution phenomenon. J. Aerosol Med. 5:261-279.
26. Kreyling, W.G., M. Semmler, F. Erbe, et al. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Env. Heal. A 65:1513-1530.
27. Gonzalez, O., R.L. Smith, and S.B. Goodman. 1996. Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J. Biomed. Mater. Res. 30: 463-473.
28. Ferin, J., G. Oberdoerster, and D.P. Penney. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 6:535-542.
29. Stearns, R.C., G.G. Murthy, and W. Skornik. 1994. Detection of ultrafine copper oxide particles in the lungs of hamsters by electron spectroscopic imaging. ICEM 13:763-764.
30. Semmler, M., J. Seitz, F. Erbe, et al. 2003. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung including transient translocation into secondary organs. Inhal. Toxicol. In press.
31. Stahlhofen, W., R. Köbrich, G. Rudolf, et al. 1990. Short-term and long-term clearance of particles from the upper human respiratory tract as function of particle size. J. Aerosol Sci. 21(1):407-410.
32. Stahlhofen, W., G. Scheuch, and M.R. Bailey. 1994. Measurements of the tracheobronchial clearance of particles after aerosol bolus inhalation. Ann. Occup. Hyg. 38:189-196.
33. Roth, C., G. Scheuch, and W. Stahlhofen. 1993. Clearance of the human lungs for ultrafine particles. J. Aerosol Sci. 24:S95-S96.
34. Roth, C., and W. Stahlhofen. 1994. Clearance measurements with radioactively labelled ultrafine particles. Ann. Occup. Hyg. 38:101-106.
35. Roth, C., W.G. Kreyling, G. Scheuch, et al. 1997. Deposition and clearance of fine particles in the human respiratory tract. Ann. Occup. Hyg. 40:503-508.
36. Kreyling, W.G., and G. Scheuch. 2000. Clearance of particles deposited in the lungs. In P. Gehr and J. Heyder, eds. Particle-Lung Interactions. Marcel Dekker, New York, 323-376.
37. Oberdörster, G., Z. Sharp, V. Atudorei, et al. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Env. Heal. A 65:1531-1543.
38. Nemmar, A., P.H. Hoet, B. Vanquickenborne, et al. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414.
39. Nemmar, A., M.F. Hoylaerts, P.H. Hoet, et al. 2003. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol. Appl. Pharmacol. 186:38-45.
40. Brooking, J., S.S. Davis, and L. Illum. 2001. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target. 9:267-279.
41. Kreuter, J., D. Shamenkov, V. Petrov, et al. 2002. Apolipoprotein- mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 10:317-325.
42. Gumbleton, M. 2001. Caveolae as potential macro-molecule trafficking compartments within alveolar epithelium. Adv. Drug Deliv. Rev. 49:281-300.
43. Oberdörster, G., and M.J. Utell. 2002. Ultrafine particles in the urban air: to the respiratory tract-and beyond? Environ. Health Perspect. 110:A440-A441.
44. Oberdoerster, G., J. Ferin, and B.E. Lehnert. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102:173-179.
45. Nel, A.E., D. Diaz-Sanchez, and N. Li. 2001. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr. Opin. Pulm. Med. 7:20-26.
46. Barnes, P.J. 2001. Neurogenic inflammation in the airways. Respir. Physiol. 125:145-154.
47. Gilmour, P.S., I. Rahman, S. Hayashi, et al. 2001. Adenoviral E1A primes alveolar epithelial cells to PM(10)-induced transcription of interleukin-8. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L598-L606.
48. Heinrich, J., B. Hoelscher, C. Frye, et al. 2002. Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany. Eur. Respir. J. 19:1040-1046.
49. Donaldson, K., V. Stone, A. Seaton, et al. 2001. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ. Health Perspect. 109:523-527.
50. Nemmar, A., H. Vanbilloen, M.F. Hoylaerts, et al. 2001. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care Med. 164:1665-1668.
51. Li, N., S. Kim, M. Wang, et al. 2002. Use of a stratified oxidative stress model to study the biological effects of ambient concentrated and diesel exhaust particulate matter. Inhal. Toxicol. 14:459-486.
52. Li, N., M. Wang, T.D. Oberley, et al. 2002. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J. Immunol. 169:4531-4541.
53. Pope, C.A., III. 1989. Respiratory disease associated with community air pollution and a steel mill, Utah Valley. Am. J. Public Health 79:623-628.
54. Ransom, M.R., and C.A. Pope, III. 1992. Elementary school absences and PM10 pollution in Utah Valley. Environ. Res. 58:204-219.
55. Pope, C.A., III, J. Schwartz, and M.R. Ransom. 1992. Daily mortality and PM10 pollution in Utah Valley. Arch. Environ. Health 47:211-217.
56. Ghio, A.J., and R.B. Devlin. 2001. Inflammatory lung injury after bronchial instillation of air pollution particles. Am. J. Respir. Crit. Care Med. 164:704-708.
57. Dye, J.A., J.R. Lehmann, J.K. McGee, et al. 2001. Acute pulmonary toxicity of particulate matter filter extracts in rats: coherence with epidemiologic studies in Utah Valley residents. Environ. Health Perspect. 109:395-403.
58. Heinrich, J., B. Hoelscher, and H.E. Wichmann. 2000. Decline of ambient air pollution and respiratory symptoms in children. Am. J. Respir. Crit. Care Med. 161:1930-1936.
59. Heinrich, J., B. Hoelscher, C. Frye, et al. 2002. Improved air quality in reunified Germany and decreases in respiratory symptoms. Epidemiology 13:394-401.
60. Gavett, S.H., L.R. Bishop, N. Haykal-Coates, et al. 2001. Effects of particles from two german cities on allergic responses in mice. Am. J. Respir. Crit. Care Med. 163:A50.
61. Shi, T., R.P. Schins, A.M. Knaapen, et al. 2003. Hydroxyl radical generation by electron paramagnetic resonance as a new method to monitor abient particulate matter composition. J. Environ. Monitor. 5:550-556.
62. Pitz, M., W.G. Kreyling, B. Holscher, et al. 2001. Change of the ambient particle size distribution in East Germany between 1993 and 1999. Atmos. Environ. 35:4357-4366.
63. Seaton, A., W. MacNee, K. Donaldson, et al. 1995. Particulate air pollution and acute health effects. Lancet 345:176-178.
64. Donaldson, K., D. Brown, A. Clouter, et al. 2002. The pulmonary toxicology of ultrafine particles. J. Aerosol Med. 15:213-220.
65. Stone, V., D.M. Brown, N. Watt, et al. 2000. Ultrafine particle-mediated activation of macrophages: Intracellular calcium signaling and oxidative stress. Inhal. Toxicol. 12:345-351.
66. Stone, V., J. Shaw, D.M. Brown, et al. 1998. The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol. Vitr. 12:649-659.
67. Beck-Speier, I., N. Dayal, E. Karg, et al. 2003. Formation of prostaglandin E-2, leukotriene B-4 and 8-isoprostane in alveolar macrophages by ultrafine particles of elemental carbon. Adv. Exp. Med. Biol. 525:117-120.
68. Lundborg, M., U. Johard, L. Lastbom, et al. 2001. Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ. Res. 86:244-253.
69. Renwick, L.C., K. Donaldson, and A. Clouter. 2001. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. 172:119-127.
70. Knaapen, A.M., T. Shi, P.J. Borm, et al. 2002. Soluble metals as well as the insoluble particle fraction are involved in cellular DNA damage induced by particulate matter. Mol. Cell. Biochem. 234-235:317-326.
71. Möller, W., T. Hofer, A. Ziesenis, et al. 2002. Ultrafine particles cause cytoskeletal dysfunctions in macrophages. Toxicol. Appl. Pharmacol. 182:197-207.
72. Geiser, M., V. Im Hof, S. Schürch, et al. 1999. Structural and interfacial aspects of particle retention. In P. Gehr and J. Heyder, eds. Particle-Lung Interactions. Marcel Dekker, New York, 291-322.
73. Borm, P.J., and W.G. Kreyling. 2003. Toxicological hazards of nanoparticles for drug delivery. J. Nanosci. Nanotech. In press.
74. Oberdoerster, G., J.N. Finkelstein, C. Johnston, et al. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health Eff. Inst. 96:5-74.
75. 2 induce generation of lipid mediators in alveolar macrophages. Environ. Health Perspect. 109:613-618.
76. Donaldson, K., V. Stone, A. Clouter, et al. 2001. Ultrafine particles. Occup. Environ. Med. 58:211-216.
77. Stone, P.H., and J.J. Godleski. 1999. First steps toward understanding the pathophysiologic link between air pollution and cardiac mortality (editorial; comment). Am. Heart J. 138:804-807.
78. Behrendt, H., and W.M. Becker. 2001. Localization, release and bioavailability of pollen allergens: the influence of environmental factors. Curr. Opin. Immunol. 13:709-715.
79. Wittmaack, K., N. Menzel, H. Wehnes, et al. 2002. Phase separation and regrowth of aerosol matter collected after size fractionation in an impactor. Atmos. Environ. 36:5877-5886.
80. Demokritou, P., T. Gupta, and P. Koutrakis. 2002. A high volume apparatus for the condensational growth of ultrafine particles for inhalation toxicological studies. Aerosol Sci. Technol. 36:1061-1072.